Skip Navigation



Human Molecular Genetics Advance Access published online on August 22, 2005

Human Molecular Genetics, doi:10.1093/hmg/ddi320
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
14/19/2881    most recent
ddi320v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kono, H.
Right arrow Articles by Honda, Z.-i.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kono, H.
Right arrow Articles by Honda, Z.-i.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved
Received June 16, 2005
Revised August 16, 2005
Accepted August 16, 2005

Article

Fc{gamma}RIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling

Hajime Kono 1, Chieko Kyogoku 2, Takeshi Suzuki 1, Naoyuki Tsuchiya 2, Hiroaki Honda 3, Kazuhiko Yamamoto 1, Katsushi Tokunaga 2, and Zen-ichiro Honda 1*

1 Department of Allergy and Rheumatology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
2 Department of Human Genetics, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
3 Department of Developmental Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan

* To whom correspondence should be addressed.
Zen-ichiro Honda, E-mail: honda-phy{at}h.u-tokyo.ac.jp


   Abstract

The B cell inhibitory receptor Fc{gamma}RIIB plays crucial roles in the maintenance of self-tolerance. We have identified a polymorphism FCGR2B c.695T > C that results in the nonconservative replacement of 232Ile at the transmembrane helix to Thr, and demonstrated the association of the polymorphism with susceptibility to systemic lupus erythematosus (SLE) in Asians. In the present study we examined the impact of FCGR2B c.695T > C on the functional properties of Fc{gamma}RIIB by expressing each allele product in a human B cell line ST486 lacking endogenous Fc{gamma}RIIB. Fc{gamma}RIIB 232Thr was found to be significantly less potent than wild type 232Ile in inhibiting B cell receptor (BCR)-mediated PIP3 accumulation, Akt and PLC{gamma}2 activation and calcium mobilization, and to display decreased levels of tyrosine phosphorylation and SHIP recruitment compared with 232Ile after IgG Fc-mediated coligation with BCR. Notably, a quantitative analysis of the subcellular distribution of Fc{gamma}RIIB using 125I-labeled anti-Fc{gamma}RIIB revealed that Fc{gamma}RIIB 232Thr less effectively distributed to detergent-insoluble lipid rafts than 232Ile, findings in accordance with the importance of the transmembrane amino acid residues, in particular large hydrophobic amino acids including Ile, in the association of membrane proteins with lipid rafts. Given the crucial roles of lipid rafts in integrating BCR signaling, decreased association of Fc{gamma}RIIB 232Thr could contribute to its impaired inhibitory potential. Collectively, the present findings indicate that the Ile232Thr substitution affects the localization and function of Fc{gamma}RIIB, and that the molecular mechanism may link the polymorphism and susceptibility to SLE.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. Kochi, K. Myouzen, R. Yamada, A. Suzuki, T. Kurosaki, Y. Nakamura, and K. Yamamoto
FCRL3, an Autoimmune Susceptibility Gene, Has Inhibitory Potential on B-Cell Receptor-Mediated Signaling
J. Immunol., November 1, 2009; 183(9): 5502 - 5510.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
X.-j. Zhou, J.-c. LV, L. Yu, Z. Cui, J. Zhao, R. Yang, J. Han, P. Hou, M.-h. Zhao, and H. Zhang
FCGR2B gene polymorphism rather than FCGR2A, FCGR3A and FCGR3B is associated with anti-GBM disease in Chinese
Nephrol. Dial. Transplant., July 29, 2009; (2009) gfp374v1.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Bournazos, S. P. Hart, L. H. Chamberlain, M. J. Glennie, and I. Dransfield
Association of Fc{gamma}RIIa (CD32a) with Lipid Rafts Regulates Ligand Binding Activity
J. Immunol., June 15, 2009; 182(12): 8026 - 8036.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Miyazaki, N. Yamasaki, H. Oda, T. Kuwata, Y. Kanno, M. Miyazaki, Y. Komeno, J. Kitaura, Z.-i. Honda, S. Warming, et al.
Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia
Blood, May 7, 2009; 113(19): 4702 - 4710.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. L. McGaha, M. C. I. Karlsson, and J. V. Ravetch
Fc{gamma}RIIB Deficiency Leads to Autoimmunity and a Defective Response to Apoptosis in Mrl-MpJ Mice
J. Immunol., April 15, 2008; 180(8): 5670 - 5679.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. J. Brownlie, K. E. Lawlor, H. A. Niederer, A. J. Cutler, Z. Xiang, M. R. Clatworthy, R. A. Floto, D. R. Greaves, P. A. Lyons, and K. G.C. Smith
Distinct cell-specific control of autoimmunity and infection by Fc{gamma}RIIb
J. Exp. Med., April 14, 2008; 205(4): 883 - 895.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Isaak, P. Gergely Jr, Z. Szekeres, J. Prechl, G. Poor, A. Erdei, and J. Gergely
Physiological up-regulation of inhibitory receptors Fc{gamma}RII and CR1 on memory B cells is lacking in SLE patients
Int. Immunol., February 1, 2008; 20(2): 185 - 192.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. B. Breunis, E. van Mirre, M. Bruin, J. Geissler, M. de Boer, M. Peters, D. Roos, M. de Haas, H. R. Koene, and T. W. Kuijpers
Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura
Blood, February 1, 2008; 111(3): 1029 - 1038.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. W. Sohn, S. K. Pierce, and S.-J. Tzeng
Live Cell Imaging Reveals that the Inhibitory Fc{gamma}RIIB Destabilizes B Cell Receptor Membrane-Lipid Interactions and Blocks Immune Synapse Formation
J. Immunol., January 15, 2008; 180(2): 793 - 799.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. R. Clatworthy, L. Willcocks, B. Urban, J. Langhorne, T. N. Williams, N. Peshu, N. A. Watkins, R. A. Floto, and K. G. C. Smith
Systemic lupus erythematosus-associated defects in the inhibitory receptor Fc{gamma}RIIb reduce susceptibility to malaria
PNAS, April 24, 2007; 104(17): 7169 - 7174.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Garcia-Garcia, E. J. Brown, and C. Rosales
Transmembrane Mutations to Fc{gamma}RIIA Alter Its Association with Lipid Rafts: Implications for Receptor Signaling
J. Immunol., March 1, 2007; 178(5): 3048 - 3058.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. van Mirre, W. B. Breunis, J. Geissler, C. E. Hack, M. de Boer, D. Roos, and T. W. Kuijpers
Neutrophil responsiveness to IgG, as determined by fixed ratios of mRNA levels for activating and inhibitory Fc{gamma}RII (CD32), is stable over time and unaffected by cytokines
Blood, July 15, 2006; 108(2): 584 - 590.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.